Maternal Metformin Treatment Improves Developmental and Metabolic Traits of IUGR Fetuses

Metformin is an anti-hyperglycemic drug widely used for the treatment of insulin resistance and glucose intolerance and is currently considered for preventing large-for-gestational-age (LGA) offspring in pregnant women affected by obesity or diabetes. Our hypothesis was the opposite—metformin may be...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biomolecules
Auteurs principaux: Garcia-Contreras, Consolación, Vazquez-Gomez, Marta, Pesantez-Pacheco, José Luis, Torres-Rovira, Laura, Heras-Molina, Ana, Encinas, Teresa, Astiz, Susana, Gonzalez-Bulnes, Antonio
Format: Artigo
Langue:Inglês
Publié: MDPI 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6572102/
https://ncbi.nlm.nih.gov/pubmed/31035702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9050166
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires